Updated Guidelines for Managing Pediatric Atopic Dermatitis

The American Academy of Pediatrics has published a new clinical report providing updated guidance for the effective management of pediatric atopic dermatitis (AD). Recognizing that many pediatricians may feel less comfortable treating dermatological conditions, the report offers a comprehensive approach based on recent advancements in treatment.

Key aspects of successful AD management include a combination of consistent skin care, topical anti-inflammatory medications, and trigger avoidance. Regular bathing using lukewarm water and gentle, fragrance-free cleansers is recommended, while products with added fragrances, dyes, or essential oils should be avoided due to their potential to cause irritation or allergic reactions.

For active eczema patches, topical treatments such as corticosteroids and calcineurin inhibitors should be applied once or twice daily. Importantly, these medications should not be mixed with emollients unless specifically directed, as this can dilute their effectiveness.

Emerging therapies like dupilumab and Janus kinase inhibitors are showing promise in treating more severe cases of AD. Advise caregivers to apply moisturizers generously over the entire body surface daily, especially after bathing, to maintain skin hydration.

To prevent flares, reducing known triggers and proactive treatment with topical anti-inflammatories are essential. Children with severe, resistant, or complicated AD should be referred to specialists for advanced care.

The report emphasizes ongoing collaboration between primary care providers and dermatology specialists to optimize outcomes for children with complex AD. This updated guidance aims to enhance clinician confidence and improve long-term skin health in pediatric patients.

Source: https://medicalxpress.com/news/2025-05-guidelines-pediatric-atopic-dermatitis.html